ConductScience.org, home

Paper39635532

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.

Rehman R and 7 others. Front Immunol, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. Papers, record 39635532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39635532

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.72, provisional
iCite
Revised in PubMed
2026-10-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rehman RRida
2Froehlich AAlbrecht
3Olde Heuvel FFlorian
4Elsayed LLobna
5Boeckers TTobias
6Huber-Lang MMarkus
7Morganti-Kossmann CCristina
8Roselli FFrancesco

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicrogliaMajor topic
Brain Injuries, TraumaticMajor topic
Animals
Mice
Male
Synapses
Mice, Inbred C57BL
Phosphorylation
Disease Models, Animal
Receptor, Fibroblast Growth Factor, Type 1
Protein Kinase Inhibitors

Source PubMed

Download CSV of topics

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132615087Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity.Cell2020https://conductscience.org/library/papers/32615087PubMed
237757826Clinical development and management of adverse events associated with FGFR inhibitors.Cell Rep Med2023https://conductscience.org/library/papers/37757826PubMed
333860438Fibroblast Growth Factor Signalling in the Diseased Nervous System.Mol Neurobiol2021https://conductscience.org/library/papers/33860438PubMed
434226493ErbB4 promotes inhibitory synapse formation by cell adhesion, independent of its kinase activity.Transl Psychiatry2021https://conductscience.org/library/papers/34226493PubMed
536403719Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update.Pharmacol Res2023https://conductscience.org/library/papers/36403719PubMed
636738678An insight into the TAM system in Alzheimer's disease.Int Immunopharmacol2023https://conductscience.org/library/papers/36738678PubMed
738447109Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits.PLoS Biol2024https://conductscience.org/library/papers/38447109PubMed
829774782The Neuroprotective Effect of Ethanol Intoxication in Traumatic Brain Injury Is Associated with the Suppression of ErbB Signaling in Parvalbumin-Positive Interneurons.J Neurotrauma2018https://conductscience.org/library/papers/29774782PubMed
936423280Cortical wiring by synapse type-specific control of local protein synthesis.Science2022https://conductscience.org/library/papers/36423280PubMed
1025913734Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.Glia2015https://conductscience.org/library/papers/25913734PubMed
1130535946The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments.Acta Neuropathol2019https://conductscience.org/library/papers/30535946PubMed
1232142677Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner.Cell2020https://conductscience.org/library/papers/32142677PubMed
1337400950The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis.Br J Pharmacol2023https://conductscience.org/library/papers/37400950PubMed
1436403069Neuronal nuclear calcium signaling suppression of microglial reactivity is mediated by osteoprotegerin after traumatic brain injury.J Neuroinflammation2022https://conductscience.org/library/papers/36403069PubMed
1529735556USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.J Neurosci2018https://conductscience.org/library/papers/29735556PubMed
1612405992Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons.Eur J Neurosci2002https://conductscience.org/library/papers/12405992PubMed
1736577378Met/HGFR triggers detrimental reactive microglia in TBI.Cell Rep2022https://conductscience.org/library/papers/36577378PubMed
1836888713Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration.Sci Adv2023https://conductscience.org/library/papers/36888713PubMed
1938825349Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1.J Neurol Neurosurg Psychiatry2024https://conductscience.org/library/papers/38825349PubMed
2036099710Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study.Lung Cancer2022https://conductscience.org/library/papers/36099710PubMed

See all 65 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42650835Electroacupuncture Prevents TBI-Induced Synaptic Loss by Inhibiting CaMKII/Drp1-Dependent Mitochondrial Fission.Biomolecules2026https://conductscience.org/library/papers/42650835PubMed
41469684Astrocytic SIRT1 ameliorates cognitive deficits after traumatic brain injury via autophagy-mediated MEGF10 phagocytosis.J Neuroinflammation2025https://conductscience.org/library/papers/41469684PubMed
40538537Erdafitinib diminishes LPS-mediated neuroinflammatory responses through NLRP3 in wild-type mice.Front Pharmacol2025https://conductscience.org/library/papers/40538537PubMed
40518115FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems.J Adv Res2025https://conductscience.org/library/papers/40518115PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39635532

GET https://conductscience.org/api/papers/v1/39635532/references?page=2